2
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Treatment of non-invasive amoebiasis—a comparison between tinidazole and metronidazole

&
Pages 505-508 | Received 07 Jan 1983, Published online: 15 Nov 2016

REFERENCES

  • Afte, U. V. & Packard, R. S. (1978). Tinidazole in the treatment of trichomoniasis, giardiasis and amoebiasis. Report of a multicentre study. Drugs, 15 (Suppl. 1), 43–48.
  • Bakshi, J. S., Ghiara, J. M. & Nanivadekar, A. S. (1978). How does tinidazole compare with metronidazole? A summary report of Indian trials in amoebiasis and giardiasis. Drugs, 15 (Suppl. 1), 33–42.
  • Catterall, R. D. (1977). Fifteen years experience with metronidazole, Proceedings of the International Metronidazole Conference, Exerpta Medica, Amsterdam, 107–111.
  • Edwards, D. I., Thompson, E. J., Tomusange, J. & Shanson, D. (1979). Inactivation of metronidazole by aerobic organisms. Journal of Antimicrobial Chemotherapy, 5, 315–316.
  • Howes, H. L., Lynch, J. E. & Kivlin, J. L. (1970). Tinidazole, a new antiprotozoal agent: effect on Trichomonas and other protozoa. Antimicrobial Agents and Chemotherapy, 6, 261–266.
  • Joshi, H. D. & Shah, B. M. (1975). A comparative study of tinidazole and metronidazole in treatment of amoebiasis. Indian Practitioner, 28, 295–302.
  • Kanani, S. R. & Knight, R. (1972). Experiences with the use of metronidazole in the treatment of non-dysenteric intestinal amoebiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 66, 244–249.
  • Misra, N. P. (1978). A comparative study of tinidazole and metronidazole as a single daily dose for three days in symptomatic intestinal amoebiasis. Drugs, 15 (Suppl. 1), 19–22.
  • Misra, N. P. & Laiq, S. M. (1974). Comparative trial of tinidazole and metronidazole in intestinal amoebiasis. Current Therapeutic Research, 16, 1255–1263.
  • Monro, A. H. (1974). Blood levels of chemotherapeutic drugs and the pharmacokinetics of tinidazole and metronidazole. Current Medical Research and Opinion, 2, 130–136.
  • Noguchi, Y. & Tanaka, T. (1978). Aspects of the pharmacology and pharmacokinetics of nitromidazoles with special reference to tinidazole. Drugs, 15 (Suppl. 1), 10–15.
  • Pehrson, P. O. (1982). Amoebiasis in a non-endemic country. Results of treatment and follow-up. Scandinavian Journal of Infectious Diseases (in press).
  • Pittman, F. E. & Pittman, J. C. (1974). Amoebic liver abscess following metronidazole therapy for amoebic colitis. American Journal of Tropical Medicine and Hygiene, 23, 146–150.
  • Powell, S. S., Macleod, I., Wilmot, A. J. & Elsdon-Dew, R. (1966). Metronidazole in amoebic dysentery and amoebic liver abscess. Lancet, 2, 1329–1331.
  • Prakash, O., Joshi, D. V., Vinayak, V. K., Dhingra, P. N. & Tarachand, A. (1970). The in vitro activity of tinidazole and other amoebicidal drugs on locally isolated strains of Entamoeba histolytica. Indian Journal of Medical Research, 58, 845–853.
  • Prakash, O., Bansal, B. C. & Bansal, M. R. (1974). Tinidazole in symptomatic intestinal amoebiasis. Journal of Tropical Medicine and Hygiene, 77, 165–167.
  • Ralph, E. D. & Clarke, D. A. (1978). Inactivation of metronidazole by anaerobic and aerobic bacteria. Antimicrobial Agents and Chemotherapy, 14, 377–383.
  • Ridley, D. S. & Hawgood, B. C. (1956). The value of formol-ether concentration of faecal cysts and ova. Journal of Clinical Pathology, 9, 74–76.
  • Roe, F. J. C. (1977). Metronidazole: review of uses and toxicity. Journal of Antimicrobial Chemotherapy, 3, 205–212.
  • Singh, G. & Kumar, S. (1977). Short course of single daily dosage treatment with tinidazole and metronidazole in intestinal amoebiasis: a comparative study. Current Medical Research and Opinion, 5, 157–160.
  • Spillman, R., Ayala, S. C. & De Sanchez, C. E. (1976). Double-blind test of metronidazole and tinidazole in the treatment of asymptomatic E. histolytica and E. hartmanni carriers. American Journal of Tropical Medicine and Hygiene, 25, 549–551.
  • Weber, D. M. (1971). Amoebic abscess of liver following metronidazole therapy. Journal of the American Medical Association, 216, 1339–1340.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.